IGM Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two
IGM Biosciences, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Two of $7.32 million as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2025-03-06
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $7.32M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $6.10M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $7.44M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $4.46M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two |
|---|---|
| 2024-12-31 | $7.32M 10-K · filed 2025-03-06 |
| 2023-12-31 | $6.10M 10-K · filed 2024-03-07 |
| 2022-12-31 | $7.44M 10-K · filed 2023-03-30 |
| 2021-12-31 | $4.46M 10-K · filed 2022-03-29 |
| 2021-09-30 | $4.39M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.86M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.17M 10-K · filed 2021-03-30 |
| 2020-09-30 | $3.17M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.17M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.09M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.09M 10-K · filed 2020-03-26 |
| 2019-09-30 | $1.94M 10-Q · filed 2019-11-07 |